IMNM
Price
$8.99
Change
-$0.13 (-1.43%)
Updated
Jun 6, 04:25 PM (EDT)
Capitalization
793.99M
68 days until earnings call
OABI
Price
$1.51
Change
+$0.13 (+9.42%)
Updated
Jun 6, 04:33 PM (EDT)
Capitalization
168.82M
Interact to see
Advertisement

IMNM vs OABI

Header iconIMNM vs OABI Comparison
Open Charts IMNM vs OABIBanner chart's image
Immunome
Price$8.99
Change-$0.13 (-1.43%)
Volume$535
Capitalization793.99M
OmniAb
Price$1.51
Change+$0.13 (+9.42%)
Volume$100
Capitalization168.82M
IMNM vs OABI Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. OABI commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and OABI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (IMNM: $9.13 vs. OABI: $1.38)
Brand notoriety: IMNM and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 55% vs. OABI: 80%
Market capitalization -- IMNM: $793.99M vs. OABI: $168.82M
IMNM [@Biotechnology] is valued at $793.99M. OABI’s [@Biotechnology] market capitalization is $168.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, IMNM is a better buy in the long-term than OABI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 7 TA indicator(s) are bullish while OABI’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 7 bullish, 3 bearish.
  • OABI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than OABI.

Price Growth

IMNM (@Biotechnology) experienced а +1.96% price change this week, while OABI (@Biotechnology) price change was +10.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.61%. For the same industry, the average monthly price growth was +17.33%, and the average quarterly price growth was +3.50%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

OABI is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+11.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($794M) has a higher market cap than OABI($169M). IMNM YTD gains are higher at: -14.077 vs. OABI (-61.017). OABI has higher annual earnings (EBITDA): -47.42M vs. IMNM (-109.95M). IMNM has more cash in the bank: 240M vs. OABI (43.6M). IMNM has less debt than OABI: IMNM (2.72M) vs OABI (22.5M). OABI has higher revenues than IMNM: OABI (26.7M) vs IMNM (10.1M).
IMNMOABIIMNM / OABI
Capitalization794M169M470%
EBITDA-109.95M-47.42M232%
Gain YTD-14.077-61.01723%
P/E RatioN/AN/A-
Revenue10.1M26.7M38%
Total Cash240M43.6M550%
Total Debt2.72M22.5M12%
TECHNICAL ANALYSIS
Technical Analysis
IMNMOABI
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 5 days ago
66%
Declines
ODDS (%)
Bearish Trend about 1 month ago
87%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPQMX5.87N/A
N/A
Principal MidCap Growth III R3
MBCZX24.18N/A
N/A
MassMutual Blue Chip Growth I
PGBEX46.02N/A
N/A
Principal Blue Chip R3
PCPAX21.49N/A
N/A
PACE Large Co Value Equity A
FCGYX19.36-0.06
-0.31%
NYLI PineStone Global Equity Class C

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+1.16%
IDYA - IMNM
60%
Loosely correlated
-0.09%
BEAM - IMNM
55%
Loosely correlated
-0.87%
RXRX - IMNM
55%
Loosely correlated
-7.13%
SYRE - IMNM
54%
Loosely correlated
+0.54%
TRDA - IMNM
52%
Loosely correlated
+2.14%
More

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with IMNM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
-1.43%
IMNM - OABI
38%
Loosely correlated
+1.16%
BEAM - OABI
37%
Loosely correlated
-0.87%
VIGL - OABI
37%
Loosely correlated
-0.25%
VCYT - OABI
37%
Loosely correlated
-1.17%
TECH - OABI
37%
Loosely correlated
-3.15%
More